Canine mammary tumours: A quantitative DNA study using static cytometry

Revista Espanola de Patologia

Volumn 44, Issue 4, 2011, Pages 195-201

  Cassali, G D ^a   Bertagnolli, A C ^b   Gärtner, Fatima ^c   Schmitt, Fernando ^c  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSIDADE VALE DO RIO DOCE   (Brazil)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

Cancer; Dog; Immunohistochemistry; Mammary; Neoplasm

Indexed keywords

BIOLOGICAL MARKER; CD31 ANTIGEN; CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR 2; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; PROTEIN P53;

ANEUPLOIDY; ANIMAL TISSUE; ARTICLE; BREAST TUMOR; CELL LINEAGE; CONTROLLED STUDY; DIPLOIDY; DISEASE ASSOCIATION; DNA CONTENT; DNA DETERMINATION; EPITHELIAL MESENCHYMAL TRANSITION; EXPERIMENTAL DOG; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALIGNANT NEOPLASTIC DISEASE; MIXED TUMOR; NONHUMAN; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS;

EID: 80455155091     PISSN: 16998855     EISSN: 1988561X     Source Type: Journal    
DOI: 10.1016/j.patol.2011.05.005     Document Type: Article

References (39)

1. Kuliffay P., Sanislo L., Galbavy S. Chromatin texture, DNA index, and S-phase fraction in primary breast carcinoma cells analysed by laserscanning cytometry. Bratisl Lek Listy 2010, 111:4-8.
2. Machado-Santelli G.M., Mori L., Pereira C.A. Prediction of relapse in patients with breast cancer by DNA cytometry. Anal Cell Pathol 1994, 7:321-334.
3. Yildirim-Assaf S., Coumbos A., Hopfenmuller W., Foss H.D., Stein H., Kühn W. The prognostic significance of determining DNA content in breast cancer by DNA image cytometry: the role of high grade aneuploidy in node negative breast cancer. J Clin Pathol 2007, 60:649-655.
4. Wenger C.R., Bearsdale S., Owens M.A., Pounds G., Oldaker T., Vendeley P., et al. DNA ploidy, S-phase, and steroid receptors in more than 127000 breast cancer patients. Breast Cancer Res Treat 1993, 28:0-20.
5. Pinto A.E., André S., Pereira T., Silva G., Soares J. Anal Cell Pathol. DNA flow cytometry but not telomerase activity as predictor of disease-free survival in pT1-2/N0/G2 breast cancer. Pathobiology 2006, 73:63-70.
6. Gilchrist K.W., Gray R., Van Driel-Kulker A.M.J., Kulker A.M.J., Mesker W.E., Ploem-Zaaijer J.J., et al. High DNA content and prognosis in lymph node positive breast cancer. A case control study by the university of Leiden and ECOG. Breast Cancer Res Treat 1993, 28:1-8.
7. Siitonen S.M., Olli-Peka K., Helin H.J., Isola J.J. Prognostic value of cells with more than 5c DNA content in node-negative breast cancer as determined by image cytometry from tissue sections. Human Pathol 1993, 24:1348-1353.
8. Misdorp W., Else R.W., Hellmen E., et al. Histological classification of the mammary tumors of the dog and the cat. World Health Organization International Histological Classification tumors of Domestic animals, Second Series 1999, vol. 7:23. AFIP, Washington, DC.
9. Möllermark G., Kängström L.E., Eliasson I., Azawedo E., Barrios C., Larsson O., et al. Distribution of nuclear DNA-content in canine mammary tumours. J Small Anim Pract 1988, 29:309-314.
10. Destexhe E., Bicker E., Coignoul F. Image analysis evaluation of ploidy, S-phase fraction and nuclear area in canine mammary tumours. J Comp Pathol 1995, 113:205-216.
11. Gärtner F., Geraldes M., Cassali G.D., Rema A., Schmitt F. DNA measurement and immunohistochemical characterization of epithelial and mesenchymal cells in canine mixed mammary tumours: putative evidence for a common histogenesis. Vet J 1999, 158:39-47.
12. Sannino P., Shousha S. Demonstration of oestrogen receptors in paraffin wax sections of breast carcinoma using the monoclonal antibody 1D5 and microwave oven processing. J Clin Pathol 1994, 47:90-92.
13. Dutra A.P., Granja N.V., Schmitt F.C., Cassali G.D. c-erbB-2 expression and nuclear pleomorphism in canine mammary tumors. Braz J Med Biol Res 2004, 37:1673-1681.
14. Castiglioni T., Elstner B., Curutchet H.P., Montesinos M., Debonis D. Immunohistochemical analysis of p53 and c-erbB-2 in breast cancer. Medicina 1995, 55:415-420.
15. Allred D.C., Harvey J.M., Berardo M., Clark G.M. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 1998, 11:155-168.
16. Weidner N., Moore D.H., Vartanian R. Correlation of Ki-67 antigen expression with mitotic figure index and tumor grade in breast carcinomas using the novel "parafin" -reactive MIB-1 antibody. Hum Pathol 1994, 25:337-342.
17. Hellmén E., Lindgren A., Linell F., Matsson P., Nilsson A. Comparison of histology and clinical variables to DNA ploidy in canine mammary tumors. Vet Pathol 1988, 25:219-226.
18. Rutteman G.R., Cornelisse C.J., Dijkshoorn N.J., Poortman J., Misdorp W. Flow cytometric analysis of DNA ploidy in canine mammary tumors. Cancer Res 1988, 48:3411-3417.
19. Scanziani E., Caniatti M., Sen S., Erba E., Cairoli F., Battocchio M. Flow cytometric analysis of cellular DNA content in paraffin wax-embedded specimens of canine mammary tumours. J Comp Path 1991, 105:p.75-p.82.
20. Pérez Alenza M.D., Rutteman G.R., Kuipers-Dijkshoorn N.J., Peña L., Montoya A., Misdorp W., et al. DNA flow cytometry of canine mammary tumours: the relationship of DNA ploidy and S-phase fraction to clinical and histological features. Res Vet Sci 1995, 58:238-243.
21. Cassali G.D., Salvador A.C., Freitas C., Dutra A., Schmitt F.C. DNA flow cytometry of canine mammary tumors: comparative aspects with human breast tumors. Arq Bras Med Vet Zootec 2007, 59:1163-1168.
22. Desinan L., Scott C.A., Pizzolitto, Avellini C., Bardus P., Rimondi G., et al. DNA flow cytometry and glial fibrillary acidic protein reactivity in pleomorphic adenomas of the salivary glands. Anal Quant Cytol Histol 1996, 18:355-360.
23. Nomura K., Fukunaga M., Uchida K., Aizawa S. Adenomyoepithelioma of the breast with exaggerated proliferation of epithelial cells: report of case. Pathol Int 1996, 4612:1011-1014.
24. Lebeau A. L'âge du chien et celui de l'homme essai de statistique sur la mortalité canine. Bul Acad Vét 1953, 26:229-232.
25. Lewis W.E. Prognostic significance of flow cytometry DNA analysis in node-negative breast cancer patients. Cancer 1990, 65:2315-2320.
26. Collechi P., Passoni A., Rocchetta M., Gnesi E., Baldini E., Bevilacqua G. Cyclin-D1 expression in node positive (N+) and node-negative (N-) infiltrating human mammary carcinomas. Inst J Cancer 1999, 84:139-144.
27. Masood S., Bui M.M., Lu L. Comparison of proliferation activity in breast carcinoma by flow cytometry analysis of S-phase and quantitative analysis of MIB-1. Ann Clin Lab Sci 1998, 28:315-323.
28. Baak J.P., Chin D., Van Diest P.J., Ortiz R., Matze-Cok P., Bacus S.S. Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer. Lab Invest 1991, 64:215-223.
29. Midulla C., De Iorio P., Nagar C., Pisani T., Cenci M., Valli C., et al. Immunohistochemical expression of p53, nm23-HI, Ki67 and DNA ploidy: correlation with lymph node status and other clinical pathologic parameters in breast cancer. Anticancer Res 1999, 19:4033-4037.
30. Marinho A., Soares R., Ferro J. Angiogenesis in breast cancer is related to age but not other prognostic parameters. Pathol Res Pract 1997, 193:267-273.
31. Nieto A., Perez-Alenza M.D., Del Castillo N., Tabanera E., Castaño M., Peña L. BRCA1 expression in canine mammary dysplasias and tumors: relationship with prognostic variables. J Comp Pathol 2003, 128:260-268.
32. Erdélyi I., Van Asten A.J.A.M., Van Dijk J.E., Nederbragt H. Expression of versican in relation to chondrogenesis-related extracellular matrix components in canine mammary tumors. Histochem Cell Biol 2005, 124:139-149.
33. Ramalho L.N.Z., Ribeiro-Silva A., Cassali G.D., Zucoloto S. The expression of p63 and cytokeratin 5 in mixed tumors of the canine mammary gland provides new insights into the histogenesis of these neoplasms. Vet Pathol 2006, 43:424-429.
34. Bertagnolli A.C., Soares P., Van Asch B., Amorim A., Cirnes L., Máximo V., et al. An assessment of the clonality of the components of canine mixed mammary tumours by mitochondrial DNA analysis. Vet J 2009, 182:269-274.
35. Pitts W.C., Rojas V.A., Gaffey M.J., Rouse R.V., Esteban J., Frierson H.F., et al. Carcinomas with metaplasia and sarcomas of the breast. Am J Clin Pathol 1991, 95:623-632.
36. Flint A., Oberman H.A., Davenport R.D. Cytophotometric measurements of metaplastic carcinoma of the breast: correlation with pathologic features and clinical behavior. Mod Pathol 1988, 1:193-197.
37. Wargotz E.S., Norris H.J. Metaplastic carcinoma of the breast: III. Carcinosarcoma. Cancer 1989, 64:490-1499.
38. Ottesen G.L., Christensen I.J., Larsen J.K., Larsen J., Christiansen J., Baldetorp B., et al. DNA ploidy analysis in breast carcinoma. Comparison of unfixed and fixed tissue analyzed by image and flow cytometry. Anal Quant Cytol Histol 1997, 19:413-422.
39. Williams R.A., Baak J.P., Meijer G.A., Charlton I.G. Testing the value of a measurement protocol for DNA image cytometry and comparing different cytologic preparations. Anal Quant Cytol Histol 1996, 18:429-437.